Cargando…

Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?

Detalles Bibliográficos
Autores principales:	Antinori, Spinello, Bonazzetti, Cecilia, Gubertini, Guido, Capetti, Amedeo, Pagani, Cristina, Morena, Valentina, Rimoldi, Sara, Galimberti, Laura, Sarzi-Puttini, Piercarlo, Ridolfo, Anna Lisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200127/ https://www.ncbi.nlm.nih.gov/pubmed/32376396 http://dx.doi.org/10.1016/j.autrev.2020.102564

Ejemplares similares

SARS-COV-2 infection: Across the border into the family
por: Antinori, Spinello, et al.
Publicado: (2020)

Bloodstream Infections in Intensive Care Unit during Four Consecutive SARS-CoV-2 Pandemic Waves
por: Pozza, Giacomo, et al.
Publicado: (2023)

Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
por: Talotta, Rossella, et al.
Publicado: (2018)

Drug–Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients
por: Cattaneo, Dario, et al.
Publicado: (2021)

Risk factors associated with bacteremia in COVID-19 patients admitted to intensive care unit: a retrospective multicenter cohort study
por: Bonazzetti, Cecilia, et al.
Publicado: (2022)

Can tocilizumab calm the cytokine storm of COVID-19?
por: Schulert, Grant S
Publicado: (2020)

Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome
por: Buskila, Dan, et al.
Publicado: (2006)

What is the role of rheumatologists in the era of COVID-19?
por: Marotto, Daniela, et al.
Publicado: (2020)

Remdesivir in moderate to severe COVID-19: A matter of time?
por: Bonazzetti, Cecilia, et al.
Publicado: (2021)

How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion
por: Sarzi-Puttini, Piercarlo, et al.
Publicado: (2020)

Candidemia in COVID‐19 treated with corticosteroids and tocilizumab
por: Yamamoto, Koichiro, et al.
Publicado: (2021)

Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome
por: Sarhan, Neven Mohamed, et al.
Publicado: (2023)

Impact of switching to TAF/FTC/RPV, TAF/FTC/EVG/cobi and ABC/3TC/DTG on cardiovascular risk and lipid profile in people living with HIV: a retrospective cohort study
por: Giacomelli, Andrea, et al.
Publicado: (2021)

Primary and secondary autoimmune neutropenia
por: Capsoni, Franco, et al.
Publicado: (2005)

Reactivation of occult hepatitis B virus infection under treatment with abatacept: a case report
por: Talotta, Rossella, et al.
Publicado: (2016)

Microbial Agents as Putative Inducers of B Cell Lymphoma in Sjögren's Syndrome through an Impaired Epigenetic Control: The State-of-The-Art
por: Talotta, Rossella, et al.
Publicado: (2019)

Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab
por: Langer-Gould, Annette, et al.
Publicado: (2020)

A Review of Chronic Musculoskeletal Pain: Central and Peripheral Effects of Diclofenac
por: Atzeni, Fabiola, et al.
Publicado: (2018)

Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy
por: Morena, Valentina, et al.
Publicado: (2020)

Imported Plasmodium vivax malaria with severe thrombocytopaenia: can it be severe malaria or not?
por: Antinori, Spinello, et al.
Publicado: (2016)

Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab
por: Benucci, Maurizio, et al.
Publicado: (2016)

Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19
por: Saha, Abinit, et al.
Publicado: (2020)

Efficacy of Tocilizumab Therapy in Different Subtypes of COVID-19 Cytokine Storm Syndrome
por: Oliynyk, Oleksandr, et al.
Publicado: (2021)

A Neonate With Cytokine Storm Managed With Steroids, Therapeutic Plasma Exchange, and Tocilizumab
por: LiKamWa, Amy, et al.
Publicado: (2023)

2648. Taming the Cytokine Storm: Baricitinib versus Tocilizumab for COVID-19 Hyperinflammation
por: Radziszewski, Skyler, et al.
Publicado: (2023)

Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence
por: Pelaia, Corrado, et al.
Publicado: (2021)

Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate
por: Batticciotto, Alberto, et al.
Publicado: (2016)

Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status
por: Antinori, Spinello, et al.
Publicado: (2020)

Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study
por: Cimmino, Marco A, et al.
Publicado: (2020)

Role of Tocilizumab in the Treatment of COVID-19 Patients with Cytokine Storm: A Case Series
por: Basnet, Ajaya, et al.
Publicado: (2022)

Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature
por: Benucci, Maurizio, et al.
Publicado: (2011)

Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
por: Benucci, Maurizio, et al.
Publicado: (2013)

The Co-Morbidity between Bipolar and Panic Disorder in Fibromyalgia Syndrome
por: Alciati, Alessandra, et al.
Publicado: (2020)

Osteoarthritis: New Insight on Its Pathophysiology
por: Coaccioli, Stefano, et al.
Publicado: (2022)

30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study
por: Giacomelli, Andrea, et al.
Publicado: (2020)

Doctors' Insights into the Patient Perspective: A Qualitative Study in the Field of Chronic Pain
por: Zanini, Claudia, et al.
Publicado: (2014)

Building bridges between doctors and patients: the design and pilot evaluation of a training session in argumentation for chronic pain experts
por: Zanini, Claudia, et al.
Publicado: (2015)

Validity of the Central Sensitization Inventory compared with traditional measures of disease severity in fibromyalgia
por: Salaffi, Fausto, et al.
Publicado: (2022)

Invasive Fungal Infections Complicating COVID-19: A Narrative Review
por: Casalini, Giacomo, et al.
Publicado: (2021)

Development and validation of the self-administered Fibromyalgia Assessment Status: a disease-specific composite measure for evaluating treatment effect
por: Salaffi, Fausto, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2jbv002i57vgvvrtk37aarvcrj